Session

Evolving knowledge in neuro-urology

Poster Session 12

  • Location:
    Room Berlin, North Hall (Level 1)
  • Chairs:
     S. Charalampous, Limassol (CY)
     T.M. Kessler, Zurich (CH)
     T.L.C. Kuo, Singapore (SG)
  • Aims and objectives of this session

    Neurological diseases can cause considerable urological problems. In this session recent advances are discussed.

  • Poster viewing of 20 minutes. Presentations will take place on stage. Standard presentations are 2 minutes in length, followed by 2 minutes for discussion. Extended presentations (*) are 3 minutes in length, followed by 3 minutes for discussion.
157
The use of mirabegron in the treatment of overactive bladder in patients affected by Parkinson’s disease

By: Gubbiotti M., Rossi De Vermandois J., Turco M., Giannantoni A.

Institutes: University of Perugia, Dept. of Surgical and Biomedical Sciences, Perugia, Italy

158
Comparison of intradetrusor injections of botulinum toxin A in adult patients with spina bifida and in patients with spinal cord injury: A multicenter study

By: Peyronnet B.1, Hascoet J.1, Roumiguie M.2, Castel-Lacanal E.3, Marque P.3, Manunta A.1, Game X.2

Institutes: 1CHU Rennes, Dept. of Urology, Rennes, France, 2CHU Toulouse, Dept. of Urology, Toulouse, France, 3CHU Toulouse, Dept. of Physical Medicine and Rehabilitation, Toulouse, France

159
Clinical profile of amyotrophic lateral sclerosis patients with lower urinary tract symptoms and neurogenic bladder: A cross-sectional study

By: Arlandis S.1, Vázquez-Costa J.F.2, Martínez-Cuenca E.1, Hervás D.3, Sevilla T.2, Broseta Rico E.1

Institutes: 1La Fe, Universitary and Polytechnic Hospital, Dept. of Urology, Valencia, Spain, 2La Fe, Universitary and Polytechnic Hospital, Dept. of Neurology, Valencia, Spain, 3Instituto De Investigación Sanitaria La Fe, Dept. of Biostatistics, Valencia, Spain

* 160
Frontal lobe function correlates with one-year incidence of urinary incontinence in elderly with Alzheimer disease

By: Yoshida M.1, Sugimoto T.2, Ono R.3, Murata S.3, Saji N.2, Niida S.4, Toba K.2, Sakurai T.2

Institutes: 1National Center For Geriatrics and Gerontology, Dept. of Urology, Obu, Japan, 2National Center For Geriatrics and Gerontology, Center For Comprehensive Care and Research On Memory Disorders, Obu, Japan, 3Kobe University, Graduate School of Health Sciences, Dept. of Community Health Sciences, Kobe, Japan, 4National Center For Geriatrics and Gerontology, Medical Genome Center, Obu, Japan

161
Feasibility, morbidity and functional results of robotic supratrigonal cystectomy with augmentation ileocystoplasty

By: Madec F-X., Hedhli O., Perrouin-Verbe M-A., Robine E., Le Clerc Q-C., Branchereau J., Le Normand L., Rigaud J.

Institutes: Nantes University Hospital, Dept. of Urology, Nantes, France

162
Intra detrusor injections of botulinum toxin type A in children with spina bifida: A multicenter study

By: Hascoet J.1, Forin V.2, Baron M.3, Capon G.4, Prudhomme T.5, Allenet C.4, Tournier S.2, Maurin C.6, Bouali O.7, Peycelon M.8, Fremond B.9, Renaux-Petel M.10, Manunta A.1, Liard A.10, Karsenty G.6, Arnaud A.9, Cornu J-N.3, Game X.5, Peyronnet B.1

Institutes: 1Rennes University Hospital, Dept. of Urology, Rennes, France, 2Trousseau Hospital, Dept. of Pediatric Physic, Paris, France, 3Rouen University Hospital, Dept. of Urology, Rouen, France, 4Bordeaux University Hospital, Dept. of Urology, Bordeaux, France, 5Toulouse University Hospital, Dept. of Urology, Toulouse, France, 6AP-HM Conception, Dept. of Urology, Marseille, France, 7Toulouse University Hospital, Dept. of Pediatric Surgery, Toulouse, France, 8Trousseau Hospital, Dept. of Pediatric Surgery, Paris, France, 9Rennes University Hospital, Dept. of Pediatric Surgery, Rennes, France, 10Rouen University Hospital, Dept. of Pediatric Surgery, Rouen, France

164
Long-term outcome of adenosine A2A receptor antagonist on lower urinary tract symptoms in male Parkinson's disease patients

By: Kitta T.1, Yabe I.2, Kanno Y.1, Ouchi M.1, Moriya K.1, Takahashi I.2, Matsushima M.2, Sasaki H.2, Shinohara N.1

Institutes: 1Hokkaido University School of Medicine, Dept. of Urology, Sapporo, Japan, 2Hokkaido University School of Medicine, Dept. of Neurology, Sapporo, Japan

* 165
Can we avoid bladder augmentation in case of failure of a first intradetrusor botulinum toxin injections in patients with spinal dysraphism?

By: Peyronnet B.1, Amarenco G.2, De Seze M.3, Schurch B.4, Even A.5, Verrando A.2, Capon G.6, Hascoet J.1, Castel-Lacanal E.7, Lenormand C.8, Maurin C.9, Biardeau X.10, Monleon L.11, Marcelli F.10, Perrouin-Verbe M-A.8, Baron M.12, Allenet C.6, Cornu J-N.12, Mouracade P.13, Boutin J-M.11, Saussine C.13, Grise P.12, Lenormand L.8, Kerdraon J.14, Chartier-Kastler E.15, Karsenty G.9, Denys P.5, Manunta A.1, Game X.7

Institutes: 1CHU Rennes, Dept. of Urology, Rennes, France, 2Tenon Hospital, Dept. of Neurourology, Paris, France, 3Clinique Saint-Augustin, Dept. of Neurourology, Bordeaux, France, 4CHU Lausanne, Dept. of Neurourology, Lausanne, France, 5Raymond Poincaré Hospital, Dept. of Neurourology, Garches, France, 6CHU Bordeaux, Dept. of Urology, Bordeaux, France, 7CHU Toulouse, Dept. of Urology, Toulouse, France, 8CHU Nantes, Dept. of Urology, Nantes, France, 9CHU Marseille, Dept. of Urology, Marseille, France, 10CHU Lille, Dept. of Urology, Lille, France, 11CHU Tours, Dept. of Urology, Tours, France, 12CHU Rouen, Dept. of Urology, Rouen, France, 13CHU Strasbourg, Dept. of Urology, Strasbourg, France, 14CHU Rennes, Dept. of Physical Medicine and Rehabilitation, Rennes, France, 15Pitié Salpétrière Hospital, Dept. of Urology, Paris, France

166
Combined treatment of DDAVP and mirabegron represents an effective treatment of neurogenic detrusor overactivity in patients with multiple sclerosis

By: Zachariou A.1, Filiponi M.2, Dimitriadis F.1, Takenaka A.3, Sofikitis N.1

Institutes: 1Ioannina University School of Medicine, Dept. of Urology, Ioannina, Greece, 2Elpis Hospital, Dept. of Urology, Volos, Greece, 3Tottori University School of Medicine, Dept. of Urology, Tottori, Japan

167
Detrusor acontractility after acute spinal cord injury: Myth or reality

By: Bywater M., Tornic J., Mehnert U., Kessler T.

Institutes: University Hospital Balgrist, Dept. of Neuro Urology, Zürich, Switzerland

168
High EDSS can predict risk for upper urinary tract damage in patients with multiple sclerosis

By: Schneider M.P.1, Ineichen B.1, Hagenbuch N.2, Linnebank M.3, Kessler T.4

Institutes: 1University Hospital of Zürich, Dept. of Neuro-Urology, Zürich, Switzerland, 2Biostatistics and Prevention Institute, Dept. of Biostatistics, Zürich, Switzerland, 3University Hospital Zürich, Dept. of Neurology, Zürich, Switzerland, 4Balgrist University Hospital, Dept. of Neuro-Urology, Zürich, Switzerland

169
Influence of botulinum toxin type A on urodynamic parameters and sexual function in men with neurogenic detrusor overactivity

By: Sivkov A.1, Romikh V.2, Panteleev V.2, Zakharchenko A.2, Arkhireev A.2, Apolikhin O.1, Kaprin A.3

Institutes: 1Research Institute of Urology and Interventional Radiology N.a. Lopatkin – Branch of Fsbi Nmrrc, Moscow, Russia, 2Research Institute of Urology and Interventional Radiology N.a. Lopatkin – Branch of Fsbi Nmrrc, Neurourology and Urodynamics, Moscow, Russia, 3Fsbi Nmrrc, Moscow, Russia